力大圖書

力大醫學圖書網 www.leaderbook.com.tw 歡迎使用國民旅遊卡！！

加入會員 | 首頁 | 服務 | 行銷回應 | 代訂 | 購物車 | 預訂清單

代訂書籍

加購書籍專區

▼ Classes
圖書類別

運費(購買金額未滿NT$1000，請自行加上運費)

-■ ■ ■ ■ ■ ■

圖書介紹

Anticancer Drug Development Guide Preclinical Screening, Clinical Trials, and Approval, Second Edition

-腫瘤科(血液科)

- 編號： 1588292282

- 作者：Teicher, Beverly A.

- 原價-5550 - (熱賣價)4625 - 節省 ↓17%

加入購物車

推薦指數：

- 內容介紹

Anticancer Drug Development Guide Preclinical Screening, Clinical Trials, and Approval, Second Edition
Teicher, Beverly A. (Genzyme Corporation, Framingham, MA)
Andrews, Paul A. (Aton Pharma, Inc., Tarrytown, NY)
Binding: Hardcover
Pub. Date: February 2004
Pages: 464
ISBN: 1588292282
Abstract:
This thoroughly updated and expanded second edition of Beverly Teicher's widely used classic survey provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included new material on the use of high throughput screening in industry, on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations, and on nonclinical testing to support both human clinical trials, as well as trials of biologic oncology products. The chapters on phase I, II, and III clinical trials and on novel phase II clinical trial designs for targeted therapies have been significantly updated, along with those on cancer drug development in Europe, working with the NCI, and the FDA's role in cancer drug development and setting requirements for approval.